Keynote - The Next Quantum Leaps in Medtech
In his keynote address, Christopher Velis, founder of Auris Health and Miraki Innovation shares insights on a repeatable process for quantum leaps of innovation. As challenges in global healthcare increase and become more urgent, momentous progress is critical. Next generation medtech companies must think beyond incremental progress while also developing lifesaving companies without missteps or delay. Auris Health was the largest medtech venture funded transaction in history, acquired by Johnson & Johnson for a total of $5.75 billion. Christopher’s method, used to develop Auris and other leading medtech companies, identifies future demands and efficiently and effectively builds the solutions to those pressing market needs. Christopher discusses the Auris story and where he sees the next big opportunities (and challenges) in medtech innovation.
Christopher J. Velis
Founder & Executive Chairman, Miraki Innovation
Panel - Big Company Executives Turned Entrepreneurs
In this panel we’ll hear the experiences and insights from ex- big company executives who’ve chosen the entrepreneurial path and are now leading early stage medtech ventures. We’ll have them share war stories, perspectives of being on both sides of the table, and find out what they are up to next -- and why. The executives on this panel have held senior positions with the some of the largest medtech strategics and have multiple exits under their belt as entrepreneurs. Join us for an informative (and fun) discussion with: Jim Corbett (Boston Scientific, ev3, MicroTherapeutics, Alphatec Spine), Todd Usen (Olympus, Smith & Nephew, Boston Scientific), Brian Verrier (Covidien, Medtronic), Paul Molloy (Telefex, VasoNova, Micardia), and Tim Moran (ConvaTec, Covidien).
CEO, Activ Surgical
Timothy P. Moran
CEO, Motus GI